Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C116847
http://purl.obolibrary.org/obo/NCIT_C116847
|
|---|---|
| Preferred Name | Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A |
| Definitions |
An immunotherapeutic agent targeting the tumor-associated antigen (TAA), cancer/testis antigen NY-ESO-1, with potential antineoplastic activity.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An immunotherapeutic agent targeting the tumor-associated antigen (TAA), cancer/testis antigen NY-ESO-1, with potential antineoplastic activity. |
|---|---|
| label | Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
|
| prefLabel | Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
|
| in_subset |
See more
See less
|
| Preferred_Name | Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
|
| Is_Value_For_GDC_Property | |
| Display_Name | Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
|
| Maps_To | Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
|
| PDQ_Open_Trial_Search_ID | 686918
|
| Has_Target | |
| prefixIRI | NCIT:C116847
|
| NCI_Drug_Dictionary_ID | 686918
|
| Contributing_Source | CTRP
|
| subClassOf | |
| code | C116847
|
| type | |
| PDQ_Closed_Trial_Search_ID | 686918
|
| Semantic_Type | Pharmacologic Substance
|
| NCI_META_CUI | CL433722
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |